Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000459370 | SCV000550570 | uncertain significance | Hereditary hemochromatosis | 2022-04-04 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 510 of the TFR2 protein (p.Ala510Thr). This variant is present in population databases (rs200053955, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with TFR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 410076). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV000765899 | SCV000897319 | uncertain significance | Hemochromatosis type 3 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000765899 | SCV001455739 | uncertain significance | Hemochromatosis type 3 | 2020-03-17 | no assertion criteria provided | clinical testing |